Irja Lutsar
Impact in
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility
- Epidemiology top 0.5%
- Fungal Infections and Studies
- Pneumonia and Respiratory Infections
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- HIV/AIDS drug development and treatment 15
- Epidemiology 60
- Pneumonia and Respiratory Infections 26
- Co-authors
- Tuuli Metsvaht (47 shared papers)Thomas J. Walsh (4 shared papers)Ian R. Friedland (8 shared papers)B. Dupont (3 shared papers)Peter F. Troke (2 shared papers)George H. McCracken (6 shared papers)Peter A. Milligan (3 shared papers)Mats O. Karlsson (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (15 papers)The Pediatric Infectious Disease Journal (8 papers)Vaccine (6 papers)Clinical Infectious Diseases (5 papers)Journal of Medical Virology (5 papers)
- Partner nations
- EstoniaUnited KingdomUnited States
In The Last Decade
Irja Lutsar
147 papers receiving 4.7k citations
Irja Lutsar's Hit Papers
Peers
Comparison fields: 5 of 132
- Infectious Diseases 2.6k
- Epidemiology 2.6k
- Microbiology 447
- Applied Microbiology and Biotechnology 139
- Molecular Medicine 289
Countries citing papers authored by Irja Lutsar
This map shows the geographic impact of Irja Lutsar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irja Lutsar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irja Lutsar more than expected).
Fields of papers citing papers by Irja Lutsar
This network shows the impact of papers produced by Irja Lutsar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irja Lutsar. The network helps show where Irja Lutsar may publish in the future.
Co-authors
The 25 scholars most cited alongside Irja Lutsar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections Hit paper breakdown → | 2003 | 508 |
| 2 | 2002 | 317 | |
| 3 | 2004 | 246 | |
| 4 | 2004 | 230 | |
| 5 | 2008 | 208 | |
| 6 | 2003 | 196 | |
| 7 | 2020 | 185 | |
| 8 | 1998 | 180 | |
| 9 | 2008 | 165 | |
| 10 | 2017 | 159 | |
| 11 | 2010 | 100 | |
| 12 | 2005 | 91 | |
| 13 | 2012 | 87 | |
| 14 | 2015 | 65 | |
| 15 | 1999 | 63 | |
| 16 | 1998 | 60 | |
| 17 | 2011 | 57 | |
| 18 | 2000 | 55 | |
| 19 | 1997 | 55 | |
| 20 | 2015 | 50 |
About Irja Lutsar
Irja Lutsar is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 152 papers that have together received 4.8k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (37 papers), Pharmaceutical studies and practices (27 papers), Pneumonia and Respiratory Infections (26 papers), HIV Research and Treatment (25 papers), Neonatal and Maternal Infections (20 papers), Bacterial Infections and Vaccines (20 papers), HIV/AIDS drug development and treatment (15 papers) and Hepatitis C virus research (13 papers). The work is most often cited by research in Infectious Diseases (2.6k citations), Epidemiology (2.6k citations), Microbiology (447 citations), Applied Microbiology and Biotechnology (139 citations) and Molecular Medicine (289 citations). Irja Lutsar has collaborated with scholars based in Estonia, United Kingdom and United States. Frequent co-authors include Tuuli Metsvaht, Thomas J. Walsh, Ian R. Friedland, B. Dupont, Peter F. Troke, George H. McCracken, Peter A. Milligan, Mats O. Karlsson, Kieren A. Marr and Timothy Driscoll. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Pediatric Infectious Disease Journal, Vaccine, Clinical Infectious Diseases and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.